“…Chronic kidney disease (CKD) is a prevalent global health issue affecting an estimated 9.1% of the population worldwide [ 1 ]. Renal replacement therapy (RRT) is a crucial aspect of managing CKD [ 2 ]. The anticipated rise in the number of individuals requiring RRT, projected to affect ∼5.4 million people globally by 2030 [ 3 ], underscores the increasing significance of efficient and safe vascular access for hemodialysis.…”